首页> 外文期刊>Current pharmaceutical design >Approaches to gastrointestinal cytoprotection: from isolated cells, via animal experiments to healthy human subjects and patients with different gastrointestinal disorders.
【24h】

Approaches to gastrointestinal cytoprotection: from isolated cells, via animal experiments to healthy human subjects and patients with different gastrointestinal disorders.

机译:胃肠道细胞保护的方法:从分离的细胞,通过动物实验到健康的人类受试者和患有不同胃肠道疾病的患者。

获取原文
获取原文并翻译 | 示例
           

摘要

Our clinical observations proved that the the duodenal ulcer in patients healed without any inhibition of gastric acid secretion (1965), and the healing rates of atropine vs cimetidine vs Carbenoxolone were equal and superior to that of placebo in randomized, prospective and multiclinical study of DU patients (1978). The phenomenon of gastric cytoprotection was defined by Andre Robert in rats (1979). The essential point of this phenomenon is that the prostaglandins prevent the chemical-induced gastric mucosal damage without affecting gastric acid secretion, this being originally suggested as a reaction specific to prostaglandins. Since then gastrointestinal cytoprotection has been shown with various agents (anticholinergic agents, H(2)RA, growth factors, body protecting compound, BPC) and retinoids in animals; the latter differing from the actions of vitamin A. In examining the various components of gastrointestinal cytoprotection , different studies have performed in isolated cells, stable cell lines, animal experiments, healthy human subjects, in patients chronic gastric and duodenal ulcers, and with different gastrointestinal disorders. Our attention has focused on the effects of cytoprotective agents on cellular viability, mitochondrial and DNA damage, oxygen free radicals, natural antioxidant systems, mucosal biochemistry, vascular events, gastrointestinal mucosal protection as well as in their prevention of different human diseases. This paper gives an overview on the different approaches for the exploring gastrointestinal cytoprotection (at the level of isolated cells, animal experiments, healthy human beings and patients with different gastrointestinal disorders). It has been indicated that the gastric cytoprotection exists in animals, human healthy subjects, patients with different gastrointestinal disorders. The our human observation in patients with duodenal ulcer healed without any changes of gastric acid secretion, there were no significant differences between the cimetidine vs. atropine (as antisecterory agents) or vs. Carbenoxolone vs. retinoid (as cytoprotective compounds) treatment. Also we indicated the presence of intact vagal nerve basically necessary for development of gastrointestinal cytoprotection and for capsaicin-sensitive vagal nerve induced mucosal protection (1982).
机译:我们的临床观察结果证明,在DU的随机,前瞻性和多临床研究中,十二指肠溃疡的he愈没有对胃酸分泌的任何抑制作用(1965年),阿托品,西咪替丁和卡贝诺酮的治愈率均相等于并优于安慰剂。患者(1978年)。胃细胞保护的现象由安德烈·罗伯特(Andre Robert)在大鼠中定义(1979年)。这种现象的本质是,前列腺素可防止化学诱导的胃粘膜损伤而不影响胃酸分泌,最初被认为是前列腺素特有的反应。从那以后,胃肠道细胞保护已在动物中表现出多种作用(抗胆碱能药,H(2)RA,生长因子,身体保护化合物,BPC)和类维生素A。后者与维生素A的作用不同。在检查胃肠道细胞保护的各种成分时,对分离的细胞,稳定的细胞系,动物实验,健康的人类受试者,慢性胃和十二指肠溃疡患者以及不同的胃肠道进行了不同的研究。疾病。我们的注意力集中在细胞保护剂对细胞生存力,线粒体和DNA损伤,氧自由基,天然抗氧化剂系统,黏膜生化,血管事件,胃肠道黏膜保护以及预防不同人类疾病的作用上。本文概述了探索胃肠道细胞保护的不同方法(在分离细胞,动物实验,健康人和患有不同胃肠道疾病的患者方面)。已经表明,胃细胞保护作用存在于动物,人类健康受试者,具有不同胃肠道疾病的患者中。我们在观察到的十二指肠溃疡患者he愈后,胃酸分泌没有任何变化,西咪替丁与阿托品(作为抗静电药)或卡贝索龙与类维生素A(作为细胞保护化合物)的治疗之间没有显着差异。我们还指出,完整的迷走神经的存在对于胃肠道细胞保护的发展和辣椒素敏感的迷走神经引起的粘膜保护是必不可少的(1982)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号